Skip to search formSkip to main contentSkip to account menu

Z 338

Known as: ACOTIAMIDE, Z-338 
A prokinetic agent with gastrointestinal (GI) motility-enhancing activity. Although the exact mechanism by which acotiamide exerts its effect has yet… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background: In Japan, novel gastric acid inhibitor vonoprazan and novel prokinetic drug acotiamide are available. Few studies… 
2017
2017
Aim: To assess the Efficacy and Safety of Acotiamide and Levosulpiride in Functional Dyspepsia Methods: Total 60 patients were… 
2016
2016
The invention discloses an acotiamide hydrochloride preparation method. The acotiamide hydrochloride preparation method includes… 
2014
2014
The invention discloses oral tablets of a kind of acotiamide hydrochloride trihydrate and preparation method thereof, acotiamide… 
2014
2014
The present invention relates to a crystalline form I of an acotiamide hydrochloride hydrate, a preparation method therefor and… 
2014
2014
The invention provides an acotiamide hydrochloride hydrate compound. Chemical name of acotiamide hydrochloride hydrate is 2-[N-(4… 
2008
2008
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following… 
2003
2003
Research efforts focusing on discovering gastroprokinetic agents with mechanisms of action different from available compounds…